Evidence map›Paper›PMID 35639948›Full record

ArticleBlood2022

PLAG1 dampens protein synthesis to promote human hematopoietic stem cell self-renewal.

Ava Keyvani Chahi, Muluken S Belew, Joshua Xu, He Tian Tony Chen, Stefan Rentas, Veronique Voisin, Gabriela Krivdova, Eric Lechman, Sajid A Marhon, Daniel D De Carvalho and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Blood, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Expansion of human hematopoietic stem cells by inhibiting translation.bioRxiv : the preprint server for biology · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Ava Keyvani ChahiDepartment of Biochemistry and Biomedical Sciences,McMaster University, Hamilton, ON, Canada.
Muluken S BelewDepartment of Biochemistry and Biomedical Sciences,McMaster University, Hamilton, ON, Canada.
Joshua XuDepartment of Biochemistry and Biomedical Sciences,McMaster University, Hamilton, ON, Canada.
He Tian Tony ChenDepartment of Biochemistry and Biomedical Sciences,McMaster University, Hamilton, ON, Canada.ORCID 0000-0001-8233-7448
Stefan RentasDepartment of Biochemistry and Biomedical Sciences,McMaster University, Hamilton, ON, Canada.ORCID 0000-0002-3189-7899
Veronique VoisinThe Donnelly Centre and.
Gabriela KrivdovaDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-7075-6124
Eric LechmanPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; and.ORCID 0000-0001-8874-2874
Sajid A MarhonPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; and.ORCID 0000-0002-1046-9852
Daniel D De CarvalhoPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; and.ORCID 0000-0003-0771-2265
John E DickDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada.ORCID 0000-0002-9527-8317
Gary D BaderThe Donnelly Centre and.ORCID 0000-0003-0185-8861
Kristin J HopeDepartment of Biochemistry and Biomedical Sciences,McMaster University, Hamilton, ON, Canada.
University Health Network · CAMcMaster University · CADonnelly College · USUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hematopoietic stem cell (HSC) dormancy is understood as supportive of HSC function and its long-term integrity. Although regulation of stress responses incurred as a result of HSC activation is recognized as important in maintaining stem cell function, little is understood of the preventive machinery present in human HSCs that may serve to resist their activation and promote HSC self-renewal. We demonstrate that the transcription factor PLAG1 is essential for long-term HSC function and, when overexpressed, endows a 15.6-fold enhancement in the frequency of functional HSCs in stimulatory conditions. Genome-wide measures of chromatin occupancy and PLAG1-directed gene expression changes combined with functional measures reveal that PLAG1 dampens protein synthesis, restrains cell growth and division, and enhances survival, with the primitive cell advantages it imparts being attenuated by addition of the potent translation activator, c-MYC. We find PLAG1 capitalizes on multiple regulatory factors to ensure protective diminished protein synthesis including 4EBP1 and translation-targeting miR-127 and does so independently of stress response signaling. Overall, our study identifies PLAG1 as an enforcer of human HSC dormancy and self-renewal through its highly context-specific regulation of protein biosynthesis and classifies PLAG1 among a rare set of bona fide regulators of messenger RNA translation in these cells. Our findings showcase the importance of regulated translation control underlying human HSC physiology, its dysregulation under activating demands, and the potential if its targeting for therapeutic benefit.

Indexed as

Hematopoietic Stem CellsTranscription FactorsCell DifferentiationCell ProliferationCell Self RenewalDNA-Binding ProteinsHumansDNA-Binding ProteinsPLAG1 protein, humanTranscription Factors

Identifiers

PMID35639948
PMCPMC9437713
OpenAlexW4281632638

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.